폐 스텐트 시장 : 예측(2025-2030년)

The lung stent market is estimated at US$156.320 million in 2025 and is expected to grow at a CAGR of 5.3% to attain US$202.422 million in 2030.

A lung stent is a type of hollow tube placed through the patient's airway. The lung stent helps in opening the narrowed area in the respiratory system. It is primarily used to treat airway and lung diseases, as well as chronic conditions such as asthma, central airway obstruction, chronic obstructive pulmonary disease, glaucoma, and lung cancer, among others. Irregular granulation tissue, lung cancer, metastatic malignancies, infections, TB, lymphoma, or other inflammatory illnesses can also cause narrowed or stenotic air passages. In most cases, tracheobronchial (airway) stents are devices that are used to splint narrowed airways open. The innovations of the stent technology are also among the factors propelling the lung stent market's growth during the estimated timeline. Similarly, the changing regulatory environment for medical technology is also estimated to boost the demand for lung stents.

Market Trends:

• Rising incidence of lung cancer: The growing number of lung cancer cases worldwide is a major driver of the lung stent market's growth during the forecast period. Lung stents are used to open blocked airways in lung cancer patients, addressing a critical need. Globally, lung cancer cases have risen significantly in recent years. For instance, the Canadian Cancer Society projects that lung cancer cases in Canada will increase from 15,800 in 2023 to 17,300, highlighting the escalating demand for lung stents.
• Aging population growth: The increasing global elderly population is another key factor driving the lung stent market. As the older population grows, the need for lung stents to maintain airway patency and relieve respiratory distress becomes more pronounced, further fueling market expansion.
• Innovations in stent technology: Advances in stent technologies, such as 3D printing, are enabling the creation of customized lung stents. These innovations provide more effective solutions and enhance patient satisfaction, contributing to the market's growth.
• North America's market dominance: North America is expected to capture a significant share of the global lung stent market due to its rapid advancements in medical technologies. The region is a leader in adopting cutting-edge technologies like 3D printing in healthcare. Additionally, government initiatives and policies aimed at improving healthcare infrastructure are expected to further boost market growth in the region.

Some of the major players covered in this report include Boston Scientific Corporation, Novatech SA, Boston Medical Products, Inc., Fuji Systems Corporation, Cook Group, Hood, E.Benson Laboratories, Inc., Merit Medical Systems, Taewoong (Olympus Global), Micro-Tech (Nanjing) Co., Ltd., S&G Biotech, Stening, MicroPort Scientific Corporation, Thoracent, Inc., and AMETEK Inc. among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Lung Stent Market is analyzed into the following segments:

By Type

• Tracheobronchial Stents
• Laryngeal Stents

By Product Type

• Self-expandable
• Balloon-expandable
• Non-expandable

By Product Material

• Metal
• Nitinol
• Stainless Steel
• Others
• Silicone
• Hybrid

By End-User

• Hospitals
• Ambulatory Surgery Center
• Others

By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LUNG STENT MARKET BY TYPE

• 5.1. Introduction
• 5.2. Tracheobronchial Stents
• 5.3. Laryngeal Stents

6. LUNG STENT MARKET BY PRODUCT TYPE

• 6.1. Introduction
• 6.2. Self-expandable
• 6.3. Balloon-expandable
• 6.4. Non-expandable

7. LUNG STENT MARKET BY PRODUCT MATERIAL

• 7.1. Introduction
• 7.2. Metal
  • 7.2.1. Nitinol
  • 7.2.2. Stainless Steel
  • 7.2.3. Others
• 7.3. Silicone
• 7.4. Hybrid

8. LUNG STENT MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Ambulatory Surgery Center
• 8.4. Others

9. LUNG STENT MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Type
  • 9.2.2. By Product Type
  • 9.2.3. By Product Material
  • 9.2.4. By End-User
  • 9.2.5. By Country
    • 9.2.5.1. USA
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. By Type
  • 9.3.2. By Product Type
  • 9.3.3. By Product Material
  • 9.3.4. By End-User
  • 9.3.5. By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Others
• 9.4. Europe
  • 9.4.1. By Type
  • 9.4.2. By Product Type
  • 9.4.3. By Product Material
  • 9.4.4. By End-User
  • 9.4.5. By Country
    • 9.4.5.1. United Kingdom
    • 9.4.5.2. Germany
    • 9.4.5.3. France
    • 9.4.5.4. Spain
    • 9.4.5.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Type
  • 9.5.2. By Product Type
  • 9.5.3. By Product Material
  • 9.5.4. By End-User
  • 9.5.5. By Country
    • 9.5.5.1. Saudi Arabia
    • 9.5.5.2. UAE
    • 9.5.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. By Type
  • 9.6.2. By Product Type
  • 9.6.3. By Product Material
  • 9.6.4. By End-User
  • 9.6.5. By Country
    • 9.6.5.1. China
    • 9.6.5.2. Japan
    • 9.6.5.3. India
    • 9.6.5.4. South Korea
    • 9.6.5.5. Taiwan
    • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Boston Scientific Corporation
• 11.2. Novatech SA
• 11.3. Boston Medical Products, Inc.
• 11.4. Fuji Systems Corporation
• 11.5. Cook Group
• 11.6. Hood, E.Benson Laboratories, Inc.
• 11.7. Merit Medical Systems
• 11.8. Taewoong (Olympus Global)
• 11.9. Micro-Tech (Nanjing) Co., Ltd.
• 11.10. S&G Biotech
• 11.11. Stening
• 11.12. MicroPort Scientific Corporation
• 11.13. Thoracent, Inc.
• 11.14. AMETEK Inc.

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations